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Abstract
Objectives:  To  describe  the  current  recommendations  on  the  best  management  of  pediatric
patients with  acute  diarrheal  disease.
Data source:  PubMed,  Scopus,  Google  Scholar.
Data summary:  There  has  been  little  progress  in  the  use  of  oral  rehydration  salts  (ORS)  in
recent decades,  despite  being  widely  reported  by  international  guidelines.  Several  studies  have
been performed  to  improve  the  effectiveness  of  ORS.  Intravenous  hydration  with  isotonic  saline
solution, quickly  infused,  should  be  given  in  cases  of  severe  dehydration.  Nutrition  should  be
ensured after  the  dehydration  resolution,  and  is  essential  for  intestinal  and  immune  health.
Dietary restrictions  are  usually  not  beneﬁcial  and  may  be  harmful.  Symptomatic  medications
have limited  indication  and  antibiotics  are  indicated  in  speciﬁc  cases,  such  as  cholera  and
moderate  to  severe  shigellosis.
Conclusions:  Hydration  and  nutrition  are  the  interventions  with  the  greatest  impact  on  the
course of  acute  diarrhea.
©  2015  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
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Diarreia  aguda:  manejo  baseado  em  evidências
Resumo
Objetivos:  descrever  as  recomendac¸ões  atuais  sobre  a  melhor  maneira  de  conduzir  o  paciente
pediátrico com  doenc¸a  diarreica  aguda.Nutric¸ão  infantil Fonte  dos  dados:  PubMed,  Scopus,  Scholar  Google.
Síntese  dos  dados:  Houve  pouco  avanc¸o  na  utilizac¸ão  dos  sais  de  reidratac¸ão  oral  (SRO)  nas
últimas décadas  apesar  de  ser  amplamente  divulgado  através  de  diretrizes  internacionais.
Vários estudos  vêm  sendo  realizados  na  tentativa  de  melhorar  a  eﬁcácia  do  SRO.  Hidratac¸ão
venosa com  soluc¸ão  salina  isotônica,  infundida  de  forma  rápida,  deve  ser  indicada  em  casos
de desidratac¸ão  grave.  A  nutric¸ão  deve  ser  assegurada  logo  após  a  resoluc¸ão  da  desidratac¸ão,
 Please cite this article as: Brandt KG, de Castro Antunes MM, da Silva GA. Acute diarrhea: evidence-based management.
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sendo  primordial  para  a  saúde  intestinal  e  imunológica.  Restric¸ões  alimentares  usualmente  não
são benéﬁcas  e  podem  ser  prejudiciais.  As  medicac¸ões  sintomáticas  têm  indicac¸ão  restrita  e
antibióticos  são  indicados  em  casos  especíﬁcos,  cólera  e  shiguelose  moderada  a  grave.
Conclusões:  a  hidratac¸ão  e  a  nutric¸ão  continuam  sendo  as  intervenc¸ões  com  melhor  impacto
sobre o  curso  da  diarreia  aguda.
© 2015  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
reservados.
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Acute  diarrheal  disease  (ADD)  is  a  public  health  problem  in
many  regions  of  the  world,  especially  where  poverty  pre-
vails.  A  model  that  aims  to  explain  the  incidence  or  mortality
associated  with  the  ADD  involves  a  large  number  of  variables
(biological,  environmental,  socio-cultural)  and  is  very  com-
plex.  Conversely,  a  reductionist  approach  contributes  little
to  the  understanding  and  solution  of  the  problem.1,2
The  scientiﬁc  community,  over  the  past  four  decades,
established  a  consensus  on  the  most  effective  measures
to  reduce  the  incidence,  morbidity,  and  mortality  of  ADD.
Some  measures  aimed  at  reducing  the  incidence  of  diar-
rheal  disease  constitute  interventions  that  are  beyond  the
medical  approach  of  the  problem  and  are  based  on  envi-
ronmental  condition  improvement:  water  supply,  adequate
treatment  of  human  waste,  education,  and  food  safety.
Exclusive  breastfeeding  for  at  least  6  months  and  supple-
mented  up  to  2  years  of  age  has  a  signiﬁcant  impact  in
reducing  the  disease  incidence  and  severity.  In  the  ﬁeld  of
biomedicine,  the  development  of  a  vaccine  against  rotavirus
and  universal  vaccine  coverage  are  important  contributions
that  have  an  impact  on  ADD  incidence,  by  decreasing  the
severe  forms  and  the  number  of  hospitalizations,  thus  reduc-
ing  the  risk  of  death.3,4
Regarding  mortality,  the  therapeutic  management  with
emphasis  on  oral  rehydration  therapy  (ORT)  and  intravenous
rehydration  therapy  (IRT),  recommended  since  the  1970s,
are  milestones  of  twentieth-century  medicine.  In  1994,
Ruxin5 wrote  an  article  commemorating  the  25th  anniversary
of  the  ORT  implementation  and  concluded  (by  observation,
and  expressing  some  pessimism):  ‘‘the  formidable  and  per-
sistent  ignorance  of  the  western  medical  establishment,
which  continues  over  twenty-ﬁve  years  after  the  discovery
of  ORT,  is  phenomenal.’’
The 21st  century  has  arrived,  and  despite  several  pub-
lished  articles  showing  the  efﬁciency  and  effectiveness  of
ORT  and  IRT,  it  can  be  observed  that  ADD  management  is
still  being  performed  in  ignorance  of  scientiﬁc  evidence.6,7
In  a  recent  article,  Walker  and  Walker2 presented  a
model,  The  Lives  Saved  Tool  (LiST),  and  analyzed  the  impact
of  using  oral  rehydration  salts  (ORS),  zinc,  and  antibiotics
for  dysentery  on  ADD  mortality  reduction.  Low-osmolality
ORS,  the  use  of  zinc  in  risk  groups  for  persistent  diarrhea,
and  use  of  antibiotics  only  in  selected  cases  of  dysentery  all
demonstrated  a  positive  impact  on  the  assessed  outcomes.
The  accumulated  scientiﬁc  knowledge  on  the  best  man-
agement  of  patients  with  ADD  is  extensive;  however,
n
h
tesearchers  have  observed  physicians’  poor  adherence  to
he  recommendations  provided  by  international  health  orga-
izations,  as  well  as  by  medical  societies,  which  periodically
ublish  guidelines  on  the  subject.1,8--10
Why  --  in  spite  of  broad  scientiﬁc  evidence  --  do  physicians
hoose  to  treat  ADD  based  on  obsolete  conduct?  This  is  the
eason  for  the  performance  of  this  review.  Even  at  present,
he  inappropriate  use  of  ORT/IRT  can  be  observed,  as  well
s  dietary  guidelines  that  are  almost  iatrogenic,  and  even
he  indication  of  medications  without  any  scientiﬁc  basis.4
herefore,  this  review  aimed  to  carry  out  a  synthesis  of
he  current  knowledge  on  ADD  management  by  focusing  on
RT/IRT,  diet  during  the  acute  diarrheal  process,  the  judi-
ious  use  of  symptomatic  medications,  probiotics,  zinc,  and
ntibiotics.
DD management
here  is  no  consensus  on  the  concept  of  ADD,  but  some
asic  aspects  have  been  covered  in  several  publications.8,9,11
n  this  review,  ADD  is  considered  as  a diarrheal  episode
hat  has  the  following  characteristics:  abrupt  onset,  pre-
umably  infectious  etiology,  potentially  self-limited,  with  a
ourse  of  less  than  14  days,  increased  volume  and/or  fre-
uency  of  stool,  and  fecal  loss  of  nutrients  (mainly  water  and
lectrolytes).  Its  major  complications  can  thus  be  inferred
hydroelectrolytic  disorders,  nutritional  deﬁcits),  providing
he  basis  for  its  management.
From  a  clinical  point  of  view,  ADD  can  be  classiﬁed
s:  watery  diarrhea  syndrome  (which  constitutes  the  vast
ajority  of  infectious  diarrheal  diseases),  bloody  diarrhea
yndrome,  and  persistent  diarrhea  (when  the  episode  lasts
ore  than  14  days).  Regardless  of  the  causative  agent,  in  the
ajority  of  diarrheal  episodes  of  infectious  etiology,  thera-
eutic  management  is  based  on  hydration  maintenance  and
utritional  status.1,4,9,12
Regarding  severity,  ADD  is  classiﬁed  as  mild,  moder-
te,  or  severe:  mild  when  signs  of  dehydration  are  not
bserved;  moderate  when  there  are  mild  or  moderate  signs
f  dehydration  and  rehydration  can  be  performed  orally;  and
evere  when  it  results  in  more  intense  dehydration  with  or
ithout  electrolyte  disturbances,  and  requires  intravenous
herapy.9,13Most  ADD  cases  show  mild  or  moderate  severity  and  are
ot  treated  at  health  services,  hence  the  importance  of
ome  treatment  guidelines  for  diarrheal  disease  in  order
o  prevent  dehydration.  Hospitals  receive  cases  with  more
S Brandt  KG  et  al.
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Table  1  Clinical  dehydration  scale  (adapted  from  Freed-
man et  al.23).
Characteristics  0  1  2
General
appearance
Normal  Thirsty,
restless,  or
lethargic,
but  irritable
when
touched
Drowsy,
limp,  cold,
sweaty;
comatose  or
not
Eyes Normal  Slightly
sunken
Very  sunken
Mucous
membranes
(tongue)
Moist  Sticky  Dry
Tears Present  Decreased
tears
Absent  tears
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xuberant  symptoms  and  dehydrated  patients  or  those  at
isk  for  dehydration;  clinical  pictures  secondary  to  severe
omiting  or  high-output  diarrhea.9,13
From  a  physiopathological  point  of  view,  there  are
wo  basic  mechanisms  involved:  osmotic  and  secretory.
econdary  to  these  mechanisms,  alterations  in  intestinal
otility  can  also  occur.  The  osmotic  mechanism  is  observed
hen  there  is  an  increase  in  luminal  osmolality,  as  it  occurs
n  diarrhea  associated  with  rotavirus,  in  which  damage
ccurs  in  the  proximal  small  bowel  mucosa,  resulting  in
ncreasing  undigested  lactose  in  the  intestinal  lumen.  The
xcess  of  lactose  when  fermented  by  bacteria  that  are  part
f  the  colonic  microﬂora,  originate  short-chain  fatty  acids,
cid  radicals  that  explain  the  distension  and  abdominal
ain,  and  in  some  cases,  perianal  hyperemia.  The  diarrhea
s  watery  and  explosive.  The  secretory  mechanism  occurs
hen  there  is  a  stimulation  of  secretion  mediators  by  the
xotoxins  produced  by  bacterial  pathogens  (Vibrio  cholerae,
nterotoxigenic  Escherichia  coli) or  by  inﬂammation  medi-
tors,  such  as  in  diarrhea  associated  with  Shigella  strains.
rom  the  viewpoint  of  fecal  losses,  what  essentially  differ-
ntiates  the  two  mechanisms  is  the  loss  of  sodium,  which  is
igher  in  the  secretory  form  and  may  be  greater  than  70  mEq
f  sodium  per  liter  of  stool.14
In  more  severe  forms  of  ADD,  in  which  high-output  diar-
hea  occurs,  it  is  important  to  characterize  the  type  of
echanism  involved  so  that  the  losses  can  be  appropri-
tely  replaced.  However,  most  ADD  pictures  in  childhood,
ven  those  that  lead  to  dehydration  and  require  hospital
reatment,  show  good  response  to  standard  management,13
hich  will  be  discussed  elsewhere  in  this  article.
The  digestive-absorptive  functions  are  maintained  in
lmost  all  children  affected  by  ADD,  and  thus,  if  an  adequate
aloric  intake  is  offered,  there  is  minimum  risk  of  malnour-
shment  or  aggravation  of  a  pre-existing  malnutrition  status.
here  are  few  situations  where  diet  restrictions  or  changes
re  necessary.  The  nutritional  approach  will  be  reviewed  in
nother  item.
ydration
ehydration  is  the  main  complication  of  acute  diarrhea,
nd  hydration  status  assessment  should  be  one  of  the  ﬁrst
ctions  to  be  taken  regarding  the  management  of  a  child
ith  diarrhea.  Acute  weight  loss  during  the  diarrheal  episode
s  considered  the  best  parameter  to  assess  dehydration.
ccording  to  the  loss,  dehydration  is  classiﬁed  as  mild  (<5%
eight  loss),  moderate  (5--10%),  or  severe  (>10%);  dehydra-
ion  severity  classiﬁcation  is  essential  for  the  treatment.9
ue  to  the  difﬁculty  in  obtaining  information  on  the  previous
eight  (to  estimate  weight  loss),  this  parameter  has  limited
ractical  usefulness,  and  other  clinical  variables  should  be
sed.
Clinical  evaluation  is  usually  used  to  deﬁne  the  hydration
tatus;  however,  it  may  show  interpersonal  variations  and,
hus,  validated  clinical  signs  capable  of  being  evaluated  in
 simple  and  objective  way  should  be  used.  The  best  signs
elated  to  moderate/severe  dehydration  are  slowed  capil-
ary  ﬁlling,  decreased  skin  turgor,  and  changes  in  breathing
attern.  Clinical  presentation  of  the  disease  can  also  alert
o  the  risk  of  dehydration,  and  a  child  with  high-output
t
t
i
IScore = 0, no dehydration; Score = 1--4, some dehydration;
Score = 5--8, moderate to severe dehydration.
iarrhea  associated  with  vomiting  has  a higher  risk  of
ehydration.9
The  use  of  scoring  systems  to  determine  the  hydration
tatus  and  disease  severity  is  considered  useful  in  the  man-
gement  of  children  with  diarrhea.  The  clinical  dehydration
cale  (CDS;  Table  1),  developed  in  2008  for  children  aged
--36  months  with  ADD  treated  in  emergency  rooms,  has
een  validated  in  several  studies.15 The  CDS  considers  four
linical  items  (overall  appearance,  eyes,  mucosa,  and  tears)
o  classify  the  child  as  ‘‘no  dehydration,’’  ‘‘some  dehy-
ration,’’  or  ‘‘moderate/severe  dehydration.’’  The  disease
everity  score  provides  a more  comprehensive  measure  of
DD  impact  on  the  child’s  health.  The  Vesikari  severity  score
Table  2) is  a  classic  score  that  has  been  recently  validated
n  a  modiﬁed  version;  it  has  demonstrated  good  applicabil-
ty  in  different  services  and  populations.16 It  does  not  assess
ydration  status,  but  rather  the  impact  of  ADD  in  different
opulations  (mild,  moderate,  and  severe)  and  the  response
o  interventions.17
Laboratory  tests  are  not  indicated  in  the  routine  assess-
ent  of  children  with  ADD,  but  can  help  determine
ehydration  severity,  with  low  levels  of  serum  bicarbonate
<15  mEq/L)  and  increase  in  urea  levels  (>10  nmol/L)  show-
ng  a good  positive  predictive  value  for  moderate  to  severe
ehydration.18
In  a dehydrated  child,  electrolyte  treatment  consists  of
ehydration  and  loss  replacement.  ORT  should  be  prefer-
bly  used  for  rehydration,  whereas  IRT  should  be  used  only
n  cases  of  ORT  failure  or  severe  dehydration.  A  systematic
eview  that  compared  the  use  of  ORT  and  IRT  in  children
ith  different  degrees  of  dehydration  concluded  that  there
as  no  difference  regarding  the  risk  of  metabolic  disorder,
ean  duration  of  diarrheal  episode,  and  need  for  ﬂuids  in
elation  to  the  type  of  therapy  used.  The  hospital  length  of
tay  was  lower  in  the  group  using  ORT.  Regarding  the  unfa-
orable  outcomes,  there  was  more  phlebitis  in  the  group
hat  received  IRT,  and  higher  incidence  of  paralytic  ileus  in
he  group  that  received  ORT.  The  ORT  failure  rate  was  1:25,
.e., for  every  25  children  that  received  ORT,  one  required
RT.19
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Table  2  Vesicari  modiﬁed  severity  score  (adapted  from  Carmo  et  al.29).
Score  0  1  2  3
Diarrhea  duration,  hours  0  1--96  97--120  ≥121
Maximum number  of  stools  in  24  h 0  1--3  4--5  ≥6
Vomiting duration,  hours 0  1--24 25--48 ≥49
Maximum  number  of  vomiting  episodes  in  24  h  0  1  2--4  ≥5
Maximum measured  temperature  (◦C)  <37  37.1--38.4  38.5--38.9  ≥39
Visit to  a  healthcare  service  --  --  Primary
healthcare  service
Hospital
emergency
Treatment  --  Venous  rehydration  Hospitalization  --
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iMild, 0--8; Moderate, 9--10; Severe, ≥11.
Intravenous  hydration  has  been  used  for  more  than  a  cen-
tury,  but  the  logistics  required  for  its  implementation  and
the  associated  complications  have  shown  that  it  is  of  little
use  when  it  is  necessary  to  hydrate  a  large  number  of  indi-
viduals  during  infectious  diarrhea  epidemics.  Around  1970,
ORS  was  developed  in  order  to  correct  dehydration  caused
by  severe  infectious  diarrhea,  particularly  cholera-related
diarrhea.  ORS  was  initially  developed  as  an  isotonic  solution,
i.e.,  osmolality  of  311  mOsm/kg  H2O  and  sodium  concentra-
tion  of  90  mEq/L,  thus  becoming  the  standard  solution  of  the
World  Health  Organization  (WHO).20
In  spite  of  the  initial  success,  there  was  a  change
in  the  world  scenario,  characterized  by  a  lower  occur-
rence  of  cholera-related  diarrhea  and  higher  incidence
of  viral  diarrhea.  In  this  context,  there  was  a  concern
regarding  the  sodium  concentration  of  the  standard  WHO
solution,  which  would  be  very  high  in  relation  to  losses
in  viral  diarrhea  cases.  Approximately  a  decade  ago,  stud-
ies  conﬁrmed  the  beneﬁt  of  using  hypotonic  solutions  with
osmolality  of  245  mOsm/kg  H2O  and  sodium  concentrations
of  60--75  mEq/L  in  non-cholera-related  diarrhea.  It  has  been
shown  that  children  who  used  hypotonic  solutions  had  less
vomiting,  lower  fecal  losses,  shorter  duration  of  disease,  and
less  need  for  intravenous  hydration  when  compared  with
those  who  used  the  solution  previously  recommended  by
the  WHO.  Hypotonic  solutions  also  contain  lower  glucose
concentrations,  which  ensure  the  adequate  ratio  for  the
coupled  transport  of  sodium  ions  and  water  by  the  intestinal
mucosa.21
To  promote  its  acceptance,  the  oral  hydration  solution
should  be  given  in  fractionated,  small  portions.  How-
ever,  the  high  volume  required  for  rehydration  may  not
be  tolerated  by  the  child,  and  solution  intake  refusal  or
even  vomiting  may  occur.  A  nasogastric  tube  (NGT)  is
indicated  in  such  circumstances,  as  well  as  in  situations
where  intravenous  or  intraosseous  hydration  is  impossible,
with  advantages  such  as:  hyper-hydration  prevention,  non-
invasiveness,  rapid  treatment  onset,  and  lower  cost.  It  has
been  demonstrated  that  hydration  via  NGT  is  as  effective  as
intravenous  hydration  in  cases  of  moderate  dehydration.22
Nevertheless,  healthcare  workers  are  more  familiar  with  the
use  of  intravenous  hydration  than  with  NGT  hydration.23The  effectiveness  of  ORS  in  reducing  morbidity  and  mor-
tality  from  acute  diarrhea  episodes  is  undeniable,  but  its
use  does  not  meet  the  goals  and  has  not  made  any  progress
in  the  last  30  years.  A  possible  explanation  for  the  lack  of
o
v
c
qrogress  regarding  the  use  of  ORS  would  be  the  fact  that,  ini-
ially,  there  was  a  large  investment  in  educational  programs
or  the  use  of  ORS,  but  with  the  emergence  of  several  other
ducational  efforts  for  ADD  prevention  and  treatment  (vac-
ination,  breastfeeding  campaigns,  nutrition,  and  hygiene),
RT  has  lost  priority.  The  need  to  maintain  educational  cam-
aigns  for  priority  use  of  ORS  should  be  emphasized,  so  that
ew  mothers  can  be  educated  about  its  use.4
Other  possible  explanations  for  the  inadequate  use  of  ORS
nclude  children’s  refusal  to  drink  it  (possibly  related  to  the
avor)  and  the  fact  that  the  oral  solution  does  not  reduce
iarrheal  losses.  Considering  this  fact,  a  way  to  improve  this
cenario  has  been  sought.  Flavored  ORS,  present  in  some
ommercial  products,  increases  its  palatability,  but  it  does
ot  appear  to  modify  the  consumed  volume.24 The  addition
f  zinc,  prebiotics,  amino  acids,  disaccharides,  and  glucose
olymers  has  resulted  in  only  a  modest  improvement  in  ORS
ffectiveness.9
The  addition  of  the  substrate  that  leads  to  the  produc-
ion  of  short  chain  fatty  acids  (SCFAs)  has  aroused  interest,
s  SCFAs  are  readily  absorbed  by  colonocytes  and  stimulate
he  absorption  of  ﬂuids  and  sodium.  Studies  have  suggested
 beneﬁt  of  adding  a  resistant  starch  (substrate  that  leads
o  the  formation  of  SCFAs  in  the  colon)  to  the  ORS.  In  a  sys-
ematic  Cochrane  review,  the  authors  found  that  the  use
f  ORS  added  to  a  resistant  starch  was  associated  with  a
educed  need  for  intravenous  infusion  and  lower  losses  from
iarrhea.25 Despite  the  possible  beneﬁts,  some  technical
roblems  are  yet  to  be  solved,  as  an  opaque  solution  is
ormed,  which  rapidly  precipitates;  the  ideal  suspension  to
olve  this  problem  has  not  been  identiﬁed  yet.
Although  preferably  ORT  should  be  used,  intravenous
ydration  is  necessary  and  crucial  in  severe  dehydration
ases.  Possible  controversies  about  what  represents  the  best
rocedure  to  implement  intravenous  hydration  are  related
o  the  type  of  ﬂuid,  the  volume,  and  rate  of  infusion.
egarding  the  type  of  solution,  there  is  evidence  that  the
sotonic  saline  solution  (0.9%  saline)  is  preferable  to  the
ypotonic  solution  (0.45%  saline),  preventing  the  occurrence
f  hyponatremia  without  causing  hypernatremia.26
As  for  the  infusion  volume  and  velocity,  studies  compar-
ng  the  infusion  of  20  mL/kg  (fast)  vs.  60  mL/kg  (ultrafast)
f  0.9%  saline  solution,  for  one  hour,  in  children  with  intra-
enous  hydration  indication  due  to  ORT  failure,  showed  that
hildren  submitted  to  ultra-fast  infusion  had  a  higher  fre-
uency  of  hypernatremia  and  later  hospital  discharge  than
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hose  submitted  to  rapid  infusion,  with  no  difference  in
ehydration  rate.  Therefore,  the  current  evidence  does  not
ustify  the  use  of  ultra-fast  rehydration.27
According  to  WHO  recommendations,  loss  replacement
hould  be  carried  out,  whenever  possible,  through  the
ral  route,  and  it  should  be  started  during  intravenous
ehydration.13 Intravenous  hydration  should  be  suspended  as
oon  as  the  child  is  hydrated  and  alert,  ensuring  the  child’s
ydration  through  ORT.  As  a  guideline,  the  WHO  recommends
 volume  of  ¼  cup  (50--100  mL)  for  children  younger  than
wo  years,  ½ cup  (100--200  mL)  for  children  aged  2--10  years,
nd  free  volume  for  those  aged  >10  years.  The  solution  to
e  used  for  diarrheal  loss  replacement  should  be  the  hypo-
onic  ORS,  but  if  it  cannot  be  used,  the  WHO  advises  using
ther  salinized  ﬂuids,  such  as  rice  water,  vegetable  broth,
nd  homemade  oral  hydration  solution.  Breast  milk  can  be
sed  as  replacement  ﬂuid  in  a  nursing  child.  However,  ﬂuids
uch  as  energy  drinks,  soft  drinks,  and  juices  high  in  sorbitol
hould  not  be  used  as  replacement  ﬂuids  due  to  low  sodium
ontent  and  high  osmolality.
The  use  of  homemade  ORS,  a  solution  prepared  by  hand
t  home  by  adding  salt  and  sugar  to  water,  is  included
n  the  Child  Health  Handbook  of  the  Brazilian  Ministry  of
ealth28 (Caderneta  de  Saúde  da  Crianc¸a do  Ministério  da
aúde  do  Brasil),  which  teaches  how  to  prepare  the  solu-
ion  by  using  the  ‘‘pinch  and  scoop’’  method  (a  handful  of
ugar  and  three  pinches  of  salt  in  200  mL  of  water).  The  ORS
an  also  be  prepared  by  using  a  measuring  spoon  and  a  tea-
poon/tablespoon.  The  WHO,  in  its  2005  document  on  acute
iarrhea  treatment,  makes  a  brief  comment  on  the  possi-
ility  of  its  use  (by  using  a  teaspoon/tablespoon),  reporting
hat,  while  potentially  effective,  it  is  not  recommended  due
o  its  inadequate  preparation  and  consumption.
A  study  carried  out  in  Ouro  Preto,  Brazil,  which  assessed
he  concentration  of  sodium  and  glucose  in  ORS  solutions
repared  by  health  workers  in  the  region,  found  a  high  per-
entage  (71.1--96.1%)  of  inadequate  preparation,  varying
ccording  to  the  preparation  method  used  (lower  inade-
uacy  was  observed  with  the  pinch  and  scoop  method).
hen  the  health  agents  were  asked  about  the  ORS  prepara-
ion  method  they  taught  to  the  families,  about  30%  reported
hey  indicated  the  use  of  the  measuring  spoon,  followed  by
he  teaspoon/tablespoon  (19%),  and  ﬁnally  the  pinch  and
coop  method  (6%).  Conversely,  only  17%  of  health  work-
rs  reported  the  availability  of  the  measuring  spoon  in  the
asic  Health  Units  (Unidades  Básicas  de  Saúde  [UBS])  of  the
egion.  In  that  study,  the  authors  point  to  the  fact  that  inade-
uate  concentration  of  solutes  and  the  balance  between  salt
nd  glucose  impairs  the  hydration  potential  of  the  home-
ade  ORS,  putting  children  at  risk;  the  main  message  of  the
tudy  was  the  lack  of  qualiﬁcation  of  the  health  workers  to
each  the  population  with  regard  to  homemade  ORS.29
In  a  systematic  review  on  the  effect  of  ORS  on  mortality
rom  diarrhea,  it  was  concluded  that  there  is  clear  evidence
hat  the  WHO  ORS  is  effective  in  reducing  mortality;  how-
ver,  there  is  no  evidence  on  the  effectiveness  of  other
omemade  solutions  (including  the  homemade  ORS)  in  com-
ating  child  death  from  dehydration.30 Despite  the  lack  of
vidence  and  possible  risks  associated  with  ORS  replacement
y  the  homemade  ORS,  the  National  Demographic  Research
n  Women’s  and  Children’s  Health  (Pesquisa  Nacional  de
emograﬁa  e  Saúde  da  Crianc¸a e  da  Mulher  [PNDS])  of  2006
a
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ound  an  increased  use  of  homemade  ORS  when  compared
o  that  observed  in  the  1996  PNDS  (16%  vs.  37%)  and  conse-
uent  decrease  in  the  use  of  ORS  in  the  same  period  (44%
s.  19%).31
Consistent  with  this  problem,  Munos  et  al.,30 in  the  pre-
iously  mentioned  systematic  review,  found  that  advising  on
he  use  of  both  ORS  and  homemade  solutions  confuses  the
opulation,  decreasing  the  effectiveness  of  the  strategy  to
ombat  mortality  from  diarrhea,  and  they  recommend  that
riority  should  be  given  to  ORS,  by  making  it  available  to  the
ntire  population.
Despite  all  considerations  about  rehydration,  the  goal  to
e  achieved  is  the  initial  prevention  of  dehydration.  Thus,
t  is  necessary,  according  to  the  strategy  proposed  by  the
HO,  to  start  ORT  at  home,  at  the  start  of  the  diarrheal
icture,  in  order  to  replace  the  losses.13 The  families  should
e  educated  about  the  early  onset  of  oral  hydration  and
vidence  of  its  failure,  such  as  vomiting  and  signs  of  dehy-
ration.  In  a  study  that  assessed  the  mother’s  knowledge  on
DD  management  in  the  city  of  Recife,  it  was  found  that
ost  mothers  did  not  have  adequate  knowledge  of  the  use-
ulness  of  ORS  in  preventing  or  treating  dehydration.  The
uthors  made  the  following  considerations:  ‘‘The  results  of
his  study  show  that,  even  with  the  improvement  in  mater-
al  knowledge  about  ORT  for  more  than  a  decade,  a  greater
ffort  is  necessary  by  health  professionals  to  create  strate-
ies  to  transmit  the  information  to  the  mothers  in  a  more
fﬁcient  manner.’’32
iet
lthough  the  maintenance  of  an  adequate  diet  for  the
hild’s  age  is  a  priority  for  intestinal  mucosa  regenera-
ion,  inadequate  feeding  practices  are  still  observed  in  the
anagement  of  children  with  acute  diarrhea.  Enterocytes
btain  their  nutrients  primarily  from  the  intestinal  lumen
ontent;  thus  fasting  or  dietary  restrictions  can  slow  down
he  renewal  process  of  the  cells  damaged  by  infectious
rocess.33 Intestinal  malabsorption,  of  higher  or  lower  sever-
ty,  may  occur  in  ADD  depending  on  the  damage  caused  by
he  pathogen;  however,  good  nutrition  must  be  ensured  and
ietary  restrictions  should  not  be  implemented  with  the  jus-
iﬁcation  of  decreasing  diarrheal  losses.  The  usual  diet  must
e  maintained  when  the  child  is  hydrated.  In  case  of  mild
o  moderate  dehydration,  food  should  be  offered  four  to
ve  hours  after  the  onset  of  rehydration.9 The  maintenance
f  breastfeeding  during  diarrheal  episode,  even  in  children
ith  mild  to  moderate  dehydration,  is  a  consensus.34
In  a  systematic  review  on  dietary  management  of  diar-
hea  in  low-  and  middle-income  countries,  a  few  points
bout  the  use  of  lactose  in  the  diet  were  analyzed.  The
ormal  amount  of  lactose  can  be  maintained  safely  in  most
hildren  with  diarrhea;  however,  the  transient  lactase  deﬁ-
iency  and  the  consequent  poor  digestion  of  lactose  can
orsen  the  diarrheal  picture  in  a small  group  of  children.
actose  restriction  would  be  beneﬁcial  in  selected  cases,
ith  reduced  losses  and  shorter  time  of  diarrheal  episode
fter  the  restriction  is  observed.  The  children  most  likely
o  beneﬁt  from  lactose  restriction  would  be  those  who
evelop  severe  dehydration  and  the  malnourished.  Lactose
estriction  by  decreasing  milk  supply,  associated  with  the
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cAcute  diarrhea  
maintenance  of  the  rest  of  the  homemade  diet,  would  be
related  to  a  better  weight  gain  compared  to  the  predomi-
nant  use  of  formulas  without  lactose.34
It  is  suggested  that,  for  children  not  yet  exposed  to  cow’s
milk-based  formula,  this  ﬁrst  exposure  should  be  avoided
during  or  shortly  after  the  ADD  episode,  to  avoid  sensitiza-
tion  to  cow’s  milk  protein.35 However,  there  is  no  evidence
that  switching  to  soy  or  hypoallergenic  formula  would  be
beneﬁcial  for  the  child.
In  children  that  have  started  a  solid  food  diet,  it  must
have  an  adequate  caloric  content,  as  well  as  macro-  and
micronutrients.  In  hospitalized  children  with  diarrhea,
higher  energy  intake  was  associated  with  shorter  duration
of  the  episode  and,  consequently,  to  a  better  outcome.36
An  adequate  diet  during  the  diarrheal  picture  can  reduce
the  occurrence  of  new  episodes.  Inadequate  nutritional
approach  during  the  diarrheal  period  can  lead  to  mal-
nutrition,  as  well  as  installation  of  the  vicious  cycle  of
malnutrition,  reduced  resistance  to  new  enteropathogens,
recurrence  of  diarrheal  episodes,  and  more
malnutrition.37
Regarding  the  use  of  handmade  or  processed  food  in  the
diet  during  the  diarrheal  episode,  no  evidence  was  found
on  the  superiority  of  industrial  formulas  compared  to  ade-
quate  homemade  diet.  Juices  with  high  fructose,  sucrose,
and  sorbitol  contents  should  be  avoided,  because  their  high
osmolality  can  exacerbate  diarrheal  losses.35
The  child  should  be  offered  a  usual  diet,  including  foods
with  ﬁber  and  fat.  Diet  supplementation  with  vegetable  oil
is  a  WHO  recommendation  to  increase  the  caloric  density
of  foods,  preventing  malnutrition.  Studies  carried  out  in  the
1990s  suggested  that  ﬁber  intake  can  decrease  the  time  of
liquid  stools.38
Anorexia  can  affect  children  with  acute  diarrhea,  a  fact
commonly  found  in  the  acute  phase  of  the  disease,  which
is  more  severe  in  the  event  of  dehydration,  acidosis,  and
hypokalemia.  The  disorders  must  be  corrected  and  food
should  be  offered  in  small  portions,  often  respecting  the
child’s  wishes.  The  lack  of  appetite  is  transient  and  the
appropriate  food  should  be  available  to  promote  nutritional
recovery  at  the  earliest  opportunity.38
Drug management of ADD
Symptomatic:  pain  and  fever
Fever  is  absent  in  most  cases  of  ADD.  Dehydration  may  lead
to  an  increase  in  body  temperature  in  young  children  and
it  can  be  an  important  symptom  in  ADD  with  blood  in  the
stool.  Fever  should  be  treated  when  >39 ◦C  or  when  the  tem-
perature  increase  is  associated  with  symptoms  that  cause
discomfort  to  the  infant.  The  antipyretic  drugs  most  fre-
quently  used  are  acetaminophen  and  metamizole.1,4,8
Cramp-like  abdominal  pain  is  a  common  symptom  of
osmotic  diarrhea  (excess  of  intestinal  gas),  and  tenesmus
is  observed  when  there  is  a  signiﬁcant  inﬂammatory  com-
ponent,  usually  in  ADD  associated  with  Shigella.  In  the
ﬁrst  case,  a  reduction  in  the  diet  supply  of  dairy  prod-
ucts  alleviates  the  symptoms;  in  the  second  case,  the
indication  of  drugs  with  analgesic  effect  --  acetaminophen
and  metamizole  --  beneﬁts  the  patient.1,4,8 Antispasmodic
d
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rugs  (scopolamine)  and  antiphysetics  agents  (simethicone)
hould  not  be  indicated.
ntiemetic  drugs
omiting  is  frequent  in  ADD,  and  antiemetics  are  excessively
rescribed  without  considering  the  intensity  of  vomiting.  In
ost  cases,  the  vomiting  ceases  when  the  child  is  hydrated,
s  dehydration,  even  when  subclinical,  can  cause  vomiting.
When  vomiting  is  sporadic,  there  is  no  indication  for
ntiemetic  use;  when  vomiting  is  intense,  there  is  an
ncreased  risk  of  dehydration  and  hospitalization,  and  these
rugs  beneﬁt  the  patients.  It  is  important  to  remember
hat  the  risk  of  side  effects  increases  when  antiemetics
re  used  in  dehydrated  patients  or  those  with  electrolyte
isturbances.39
Among  the  most  commonly  used  drugs  are:  H1-
istamine  receptor  blockers  (promethazine,  dimenhydri-
ate),  dopamine  receptor  antagonists  (metoclopramide),
nd  serotonin-5HT  (ondansetron).
The  literature  does  not  have  good  scientiﬁc  evidence  that
upports  the  use  of  metoclopramide  and  dimenhydrinate  in
DD.39 Regarding  ondansetron,  several  studies  have  shown
hat  it  reduces  the  risk  of  dehydration  and  hospitalization  in
he  subset  of  patients  with  a high  frequency  of  vomiting.40
ntidiarrheal  drugs
he  search  for  drugs  that  act  by  reducing  the  volume  of
tool  and/or  the  time  of  diarrheal  episode  has  been  the
ubject  of  a  constant  search.  Studies  with  adsorbents,  alu-
inum  silicate,  and  diosmectite  are  found  in  the  literature,
ut  without  encouraging  results.  Loperamide,  an  antimotil-
ty  drug,  was  banned  from  pediatric  prescription  since  its
oxic  effects  were  identiﬁed  as  associated  with  the  central
ervous  system,  in  addition  to  the  risk  of  causing  paralytic
leus.41
Among  the  drugs  classiﬁed  as  adsorbents,  kaolin--pectin
as  used  in  the  past,  but  its  use  was  discontinued,  as  its
ffectiveness  was  not  demonstrated.  Its  cosmetic  effect
f  making  the  stool  semi-solid,  without  changing  the  ﬂuid
olume,  could  give  the  impression  of  an  improved  clinical
icture  and  could  reduce  diarrheal  surveillance  in  relation
o  ﬂuid  supply.  Another  drug,  diosmectite,  a  natural  product
ased  on  aluminum  silicate  and  magnesium  that  is  not  com-
ercialized  in  Brazil,  has  been  the  object  of  studies,  but  its
ffectiveness  has  not  been  demonstrated.41
The  international  guidelines  are  unanimous  in  stating
hat  there  is  no  indication  for  the  use  of  these  drugs  in
DD.1,4,8,9
ntisecretory  drugs
n  ADD  pictures  in  which  the  secretory  mechanism  is  involved
nd  diarrheal  losses  are  important,  the  use  of  racecadotril
an  beneﬁt  patients.  By  reducing  fecal  loss  and  disease
uration  (it  affects  the  secretory  process  by  inhibiting  the
nkephalinase),  it  facilitates  the  hydration  status  mainte-
ance  and,  therefore,  reduces  the  chance  of  hospitalization.
n  these  cases,  ORT  has  been  recommended  as  adjuvant
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herapy;  there  is  no  evidence  that  its  use  reduces  the  need
or  IRT.42
inc
n  2004,  the  WHO  and  UNICEF  brought  attention  to  the
mpact  of  zinc  in  reducing  the  severity  of  the  diarrheal
pisode  and  the  number  of  subsequent  ADD  episodes  in  chil-
ren  younger  than  5  years.  The  explanation  for  this  effect
ould  be  the  modulation  of  the  immune  system  and  also
ecause  it  has  an  antisecretory  property.43
Most  studies  were  conducted  in  poor  regions  and
ecruited  children  at  higher  risk  of  developing  more  severe
iarrheal  episodes,  including  persistent  diarrhea.  At  that
oment,  the  recommendation  was  to  use  zinc  associated
ith  ORT  for  all  children  younger  than  5  years  old.  Later
tudies  in  developed  regions,  which  recruited  children  at  low
isk  for  severe  and/or  persistent  diarrhea,  showed  no  addi-
ional  beneﬁt  of  the  use  of  zinc.  Currently,  the  indication
s  restricted  to  children  belonging  to  risk  groups  that  origi-
ate  mainly  from  the  poorest  regions:  malnourished  children
ounger  than  5  years  of  age  and  those  with  history  of  previ-
us  episodes  of  ADD  or  hospitalization.44
robiotics
nly  some  strains  of  probiotics  have  been  studied  in  the  ADD
ontext.  Such  studies  should  be  carefully  analyzed  regarding
he  evaluated  outcomes  and  assessed  strains,  because  there
re  different  mechanisms  of  action;  what  is  assessed  in  rela-
ion  to  a  strain  cannot  simply  be  transferred  to  another.
actobacillus  GG  and  Saccharomyces  boulardi  are  the  most
ften  scientiﬁcally  tested.
The  action  of  probiotics  occurs  mainly  through  antag-
nism,  immunomodulation,  or  pathogen  exclusion.  The
ntagonism  and/or  exclusion  can  have  a  short-term  effect
n  ADD.45
Most  studies  were  carried  out  in  developed  countries.
hey  analyzed  the  following  variables  as  outcome:  duration
f  diarrheal  episode,  reduction  of  fecal  losses,  and  hospi-
alization,  and  found  a  beneﬁcial  effect.  It  is  necessary  to
onduct  studies  to  analyze  the  cost-beneﬁt  of  using  probio-
ics  as  an  adjunct  therapy  to  ORT/IRT  in  underdeveloped  and
eveloping  countries.8,12
ntibiotics
ntibiotics  are  not  indicated  in  most  ADD  episodes,  even
hen  the  cause  is  bacterial.  Almost  all  cases  have  a self-
imited  and  benign  course,  as  long  as  the  patient  remains
ydrated.  Even  in  the  most  severe  diarrheal  episodes,  the
se  of  antimicrobials  is  a  conduct  of  exception.
The  main  issue  to  be  highlighted  is  that  there  is  no  effec-
ive  antibiotic  therapy  for  most  agents  associated  with  ADD.
urthermore,  the  indiscriminate  use  may  bring  harm  to  the
atient  due  to  the  devastating  effect  in  the  intestinal  micro-
iota,  an  important  mechanism  of  protection.
The  WHO  recommends  the  use  of  antimicrobial  drugs  in
evere  cases  of  ADD  associated  with  Shigella  (ciproﬂoxacin,
eftriaxone)  and  cholera  (tetracycline,  erythromycin).Brandt  KG  et  al.
hen  the  causative  agent  is  a  protozoan,  the  etiological
reatment  is  rarely  indicated,  except  in  immunodepressed
atients.1,8,9
inal  considerations
n  2005,  the  World  Health  Organization  revised13 the  guide-
ines  for  ADD  treatment,  and  deﬁned  the  treatment  goals:
revent/treat  dehydration,  prevent  nutritional  aggrava-
ion,  and  reduce  the  duration  and  severity  of  diarrheal
pisode.  These  goals  can  be  achieved  through  the  proper
se  of  ORT/IRT,  maintenance  of  adequate  food  intake
nd,  in  some  cases,  judicious  use  of  symptomatic  med-
cation  (antipyretic,  analgesic,  and  anti-emetic  drugs),
inc,  antisecretory  drugs,  probiotics,  and  antibiotics.  These
ecommendations  remain  unaltered  and  almost  all  interna-
ional  guidelines  published  since  then  corroborate  them.
Despite  the  scientiﬁc  evidence  supporting  this  conduct,
hy  are  children  not  being  adequately  treated  in  practice?
hy  do  pediatricians  not  adhere  to  the  guidelines?
The  explanation  is  not  simple  and  involves  several
spects:  the  fact  that  the  families  expect  medical  care  to
ffer  an  intervention  that  will  result  in  a  rapid  disappear-
nce  of  symptoms;  the  belief  that,  for  each  disease,  there
s  a  medication  that  will  immediately  terminate  the  patho-
ogical  process;  and  the  difﬁculty  physicians  have  in  building
 trusting  relationship  during  consultations  that  often  last
nly  a  few  minutes.
Nevertheless,  researchers  worldwide  have  been  evaluat-
ng  intervention  studies  on  ADD  and  assessing  which  conducts
ctually  have  a  scientiﬁc  basis.  The  consensus  is  that  the
aintenance  of  hydration  status  and  proper  nutrition  are
he  recommended  interventions  for  almost  all  children  with
DD.
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